Demographics and Overall Bladder Activity and Volume
| Parameter | Data |
| Age (y) | 69 (64–73) |
| 18F-fluciclovine dose (MBq) | 381.1 (362.6–392.2) |
| Aorta SUVmean | 1.6 (1.4–1.8) |
| Marrow SUVmean | 3.3 (2.7–3.9) |
| Liver SUVmean | 8.6 (7.5–10.3) |
| Bladder SUVmax | 3.1 (1.1–6.0) |
| Bladder SUVmean | 1.6 (1.6–3.6) |
| Bladder SUVmean/aorta SUVmean ratio | 1.1 (0.4–2.3) |
| Bladder SUVmean/marrow SUVmean ratio | 0.5 (0.2–1.1) |
| Bladder SUVmean/liver SUVmean ratio | 0.2 (0.1–0.5) |
| Bladder radioactivity | |
| Bladder visualized on maximum-intensity projection | 53.5% (85/159) |
| Quantitation | |
| Insignificant (bladder SUVmean < aorta SUVmean) | 48.4% (77/159) |
| Mild (bladder SUVmean ≥ aorta SUVmean < marrow SUVmean) | 20.8% (33/159) |
| Moderate (bladder SUVmean ≥ marrow SUVmean < liver SUVmean) | 22.0% (35/159) |
| Intense (bladder SUVmean ≥ liver SUVmean) | 8.8% (14/159) |
| Bladder volume (mL) | |
| Bladder volume (n = 159) | 34.4 (18.6–77.9) |
| Insignificant (n = 77) | 64.9 (43.7–102.4), P < 0.001 |
| Mild (n = 33) | 26.4 (16.9–62.5), P = 0.004 |
| Moderate (n = 35) | 20.7 (14.2–30.9), P < 0.001 |
| Intense (n = 14) | 20.2 (14.1–26.3), P < 0.001 |
Data are median or percentage, with IQR or n in parentheses. Total n = 159.